Plasmid Gene Therapy
Showing 1 - 25 of >10,000
Peripheral Artery Disease Trial in Beijing (NL003, Placebo)
Recruiting
- Peripheral Artery Disease
- NL003
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck
Terminated
- Metastatic Head and Neck Squamous Cell Carcinoma
- +2 more
- ImmunoPulse
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 1, 2022
Arterial Occlusive Disease, Ischemia, Ulcers Trial in China (NL003, Normal Saline)
Recruiting
- Arterial Occlusive Disease
- +3 more
- NL003
- Normal Saline
-
Beijing, Beijing, China
- +13 more
Mar 29, 2022
Arterial Occlusive Disease, Ischemia, Ulcers Trial in China (NL003, Normal Saline)
Recruiting
- Arterial Occlusive Disease
- +3 more
- NL003
- Normal Saline
-
Beijing, Beijing, China
- +12 more
Mar 29, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Transfusion-dependent Beta-thalassemia After Gene Therapy
Recruiting
- Transfusion-dependent Beta-Thalassemia
- Gene Therapy
- Gene therapy
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Aug 6, 2023
Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
Not yet recruiting
- Sickle Cell Disease
- Interview
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 30, 2023
To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
Not yet recruiting
- To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
- (no location specified)
Aug 29, 2023
Liver Biopsy Following Gene Therapy For Hemophilia
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Liver Biopsy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 27, 2023
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
Oct 12, 2023
Sensorineural Hearing Loss, Bilateral Trial in Philadelphia (AAVAnc80-hOTOF via Akouos Delivery Device)
Recruiting
- Sensorineural Hearing Loss, Bilateral
- AAVAnc80-hOTOF via Akouos Delivery Device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Apr 18, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong University Sc
Sep 26, 2023
Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)
Active, not recruiting
- Retinitis Pigmentosa
- subretinal injection of rAAV.hPDE6A
-
Tuebingen, GermanyUniversitätsklinikum Tübingen, Department für Augenheilkunde
Dec 7, 2022
Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200 Gene Therapy)
Active, not recruiting
- Lysosomal Storage Disease
- Metachromatic Leukodystrophy
- OTL-200 Gene Therapy
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 4, 2022
Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC Trial (LX2020)
Not yet recruiting
- Arrhythmogenic Cardiomyopathy
- +2 more
- LX2020
- (no location specified)
Oct 25, 2023
l Gene Editing Therapy for Cardiovascular Disease
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Auckland, New Zealand
- +2 more
Oct 31, 2023
HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle
Recruiting
- HER2 Negative Breast Carcinoma
- +6 more
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 18, 2022
Hypertriglyceridemia, Familial Trial in Nanjing (GC304)
Not yet recruiting
- Hypertriglyceridemia, Familial
- GC304
-
Nanjing, ChinaAffiliated Jinling Hospital, Medical School, Nanjing University
May 5, 2023
To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD Trial (LX109)
Not yet recruiting
- To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
- (no location specified)
Sep 1, 2023
X-linked Retinoschisis Trial (ATSN-201)
Not yet recruiting
- X-linked Retinoschisis
- ATSN-201
- (no location specified)
May 26, 2023
Hemophilia A, Gene Therapy Trial in Tianjin (Injection of GS001)
Recruiting
- Hemophilia A
- Gene Therapy
- Injection of GS001
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Sep 19, 2022
Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)
Not yet recruiting
- Gaucher Disease, Type 3
- Gene therapy
- Enzyme Replacement Agent
- (no location specified)
Apr 14, 2023